Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Prenetics Global Limited - Class A Ordinary Share
(NQ:
PRE
)
5.160
-0.140 (-2.64%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Prenetics Global Limited - Class A Ordinary Share
< Previous
1
2
Next >
Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry
August 19, 2024
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Global (NASDAQ: PRE): Bending Biotech with Beckham
July 12, 2024
Via
AB Newswire
Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham
July 11, 2024
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors
July 01, 2024
Adding Decades of Public Company and Board Expertise as Prenetics Readies for Expansion into Consumer Health and Wellness
From
Prenetics Limited
Via
GlobeNewswire
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating
January 25, 2023
From
Prenetics Global Limited
Via
ACN Newswire
Prenetics Global Limited (NASDAQ: PRE): Genomic Innovations Making Waves in Cancer Care
June 20, 2024
Via
AB Newswire
Prenetics Announces First Quarter 2024 Financial Results
June 18, 2024
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
June 17, 2024
~ Emphasizes Strong Cash Position, No Debt, and A Dedicated Management Team Focused on Delivering Growth and Value to Shareholders ~
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
April 01, 2024
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station
February 09, 2024
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Announces Third Quarter 2023 Financial Results
November 20, 2023
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Global Limited Announces Reverse Stock Split
November 01, 2023
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Announces Second Quarter 2023 Financial Results
September 15, 2023
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Global signs "transformational" $200mln deal to create cancer screening JV
June 30, 2023
Prenetics Global Ltd (NASDAQ:PRE) CEO Danny Yeung speaks to Thomas Warner from Proactive after announcing a $200mln deal to create a multi-cancer early detection screening joint venture with Professor...
Via
TheNewswire.com
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening
June 25, 2023
Company will Host Conference Call to Discuss the Transaction on June 26 at 8:30 a.m. EDT
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Announces First Quarter 2023 Financial Results
June 05, 2023
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
March 14, 2023
New Business Strategy Focused on Precision Oncology
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
March 02, 2023
From
Prenetics Limited
Via
GlobeNewswire
Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 02, 2023
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA
January 19, 2023
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors
January 10, 2023
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
December 16, 2022
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics
December 16, 2022
From
Prenetics Global Limited
Via
ACN Newswire
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index
November 30, 2022
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index
November 30, 2022
From
Prenetics Global Limited
Via
ACN Newswire
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
November 10, 2022
Via
ACN Newswire
Exposures
COVID-19
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
November 10, 2022
From
Prenetics Limited
Via
GlobeNewswire
Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook
September 09, 2022
Via
ACN Newswire
Exposures
COVID-19
Younger Colorectal Cancer Population Highlights the Importance of Early Screening, Highly Sensitive Test Product Prenetics has Launched the Market
September 01, 2022
Via
ACN Newswire
Above Phone partners with Presearch on secure, private phone
August 25, 2022
Above Phone will now ship with Presearch as default web browser and search engine.
Via
IssueWire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.